Skip to content
Close
SEARCH

CEO & BOARD

Helping life science CEOs and boards navigate complexity, make choices, and drive progress

Unlocking future value

CEOs and boards lead at critical inflection points, making high-stakes choices and investment decisions that shape the future of their organisations. Today’s executive leaders face transformation pressure from shifting innovation models, new business models and ecosystem opportunities, and geopolitical uncertainty. Delivering on shareholder expectations requires more than a strong vision – it demands disciplined strategy-execution, clear communication of priorities, and a deliberate evolution of culture to keep pace with change.

At Biobridge Partners, we serve as a trusted partner to CEOs and boards across pharma, biotech, and ecosystem players. We help set direction, clarify short- and long-term value drivers, and transform organisations to deliver on strategic objectives. Our consultants work closely with executive teams to navigate complexity, make choices, and drive progress. Explore how we can help you progress with confidence.

Navigate complexity

Market shifts and volatility, rising competitive pressure, and ongoing geopolitical uncertainty set the scene for the trade-offs life science CEOs and boards must make when setting strategic direction and allocating resources. Navigating these tensions requires a sharp focus on underlying value drivers, rigorous data analysis to understand the past, and imagination to envision the future. We help executive teams bring structure to this complexity by clarifying what matters most and mapping practical paths to value creation.

Examples of projects where we successfully helped CEOs and Boards navigate complexity:

  • Scenario planning to inform long-term direction and challenge assumptions
  • Business plan and investor presentation for emerging biotech preparing fund-raising
  • Full potential study to inform investment decisions in R&D

Make choices

Life science CEOs and boards face critical choices that set the course for growth, resilience, and shareholder value – from entering new markets and therapeutic areas, to reshaping portfolios, funding innovation, and managing risk. We help you make confident, high-stakes choices by structuring options, clarifying trade-offs, and aligning key stakeholders. Our approach is pragmatic and action-oriented, ensuring that choices are grounded in your strategic and operational reality.

Examples of projects where we successfully helped executives make choices:

  • Therapy area strategy to set direction for global development

  • Identifying and evaluating M&A and partnership opportunities

  • Redesigning governance structures to support future growth

 

Drive progress

Impact comes not only from the right strategic choices, but from ensuring solutions are owned and made relevant across the organisation, championed by leadership, and delivered at pace. We work closely with executive teams to secure organisational buy-in, mobilise teams around a shared agenda, and drive measurable results and cultural change. Our approach to building transformation muscle and management systems ensures new ways of working are embedded and that progress is sustained at every level.

Examples of projects where we successfully helped executives drive progress:

  • Developing synergy plan for post-merger integration in large-scale corporate M&A
  • Preparing the organisational development plan for rapid scaling
  • Refocusing commercial operating model following demerger from big pharma

Start a conversation with our team 

Whether you are navigating a challenge, seeking insights, or exploring a collaboration, we would love to hear from you.
Get in touch

Meet the experts

Our team of life science strategists blends international experience and backgrounds from MDs, PhDs, and top-tier strategy consulting. We engage with a structured and collaborative approach to develop practical solutions to complex problems. Meet our team of experienced life science consultants.

Daniel Schmidt
TOUCH
Daniel Schmidt PartnerDaniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Daniel Schmidt Partner
Jonas Karlsen
TOUCH
Jonas Karlsen PartnerJonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.
Jonas Karlsen Partner
Jens Rommer
TOUCH
Jens Rommer PartnerJens is a seasoned strategy advisor with 30 years of experience in management consulting. Former Head of Monitor Deloitte Denmark, he brings deep expertise in shaping corporate agendas, TA strategies, operating model design, digital and AI value creation, and M&A for leading global corporations.
Jens Rommer Partner
Florian Preis
TOUCH
Florian Preis PrincipalFlorian is a life science strategist supporting pharma and biotech leaders shape therapeutic area and launch performance. He is an expert in translating global strategic direction into market-level execution, and in the operating models that make it hold. He works hypothesis-led and close to the client, bringing a point of view early and sharpening it through rigorous analysis.
Florian Preis Principal
Johannes Bæk Christensen
TOUCH
Johannes Bæk Christensen Project LeaderJohannes is a life science strategist supporting clients translate strategic choices into operating models that hold up in execution. He is an expert in structuring complex problems into distinct options and pressure-testing them against the organisations that must run them. He has a particular focus on how AI reshapes business models and ways of working across the value chain.
Johannes Bæk Christensen Project Leader
Mette Brøgger-Mikkelsen, MD
TOUCH
Mette Brøgger-Mikkelsen, MD Project LeaderMette blends medical expertise with strategic experience as a medical doctor and former strategy consultant. Before joining Biobridge Partners, she worked at Bain & Company and LEO Innovation Lab. She focuses on cross-functional engagement in medical and commercial functions in pharma.
Mette Brøgger-Mikkelsen, MD Project Leader
Alfred Bukh Johannesen
TOUCH
Alfred Bukh Johannesen Senior ConsultantAlfred is a seasoned life science strategy consultant with a background from Monitor Deloitte and 3+ years’ experience helping clients articulate and assess strategies, develop strategic options, and translate strategic intent into actionable plans.
Alfred Bukh Johannesen Senior Consultant
Amadou Benavent
TOUCH
Amadou Benavent Senior ConsultantAmadou brings a cross-disciplinary background in Biotechnology and Business Administration. He has experience in strategic projects spanning the full pharmaceutical value chain, from early research to development and commercial strategy.
Amadou Benavent Senior Consultant
Daniell I. F. Skourup
TOUCH
Daniell I. F. Skourup Marketing LeadDaniell leads marketing at Biobridge Partners, helping shape the firm’s positioning, narrative, and go-to-market execution across brand and thought leadership. He brings a background in design and concept development, including experience as a product designer on the health app SELF and 3 years leading marketing at BASE life science.
Daniell I. F. Skourup Marketing Lead
Caroline Clausen
TOUCH
Caroline Clausen AnalystCaroline brings a strong international background and a passion for life science and its potential for impact. She is pursuing a B.Sc. in International Business at CBS, with a growing focus on strategy, market access, and business development in the life sciences sector.
Caroline Clausen Analyst
Anton Oliver Klapp
TOUCH
Anton Oliver Klapp AnalystAnton is a life science strategy analyst with a cross-disciplinary background in molecular medicine and business administration. He has hands-on experience in gene and cell therapy research and focuses on translating scientific innovation into real-world impact through strategic insight.
Anton Oliver Klapp Analyst
Bertram Toft Kristiansen
TOUCH
Bertram Toft Kristiansen AnalystBertram brings prior experience in life science and a strong interest in strategy and business development. He is pursuing a B.Sc. in International Business at CBS, with a focus on market entry and growth topics within the life sciences sector.
Bertram Toft Kristiansen Analyst
Nicolai Hesdorf
TOUCH
Nicolai Hesdorf Chair of the Board of DirectorsNicolai is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Senior Partner and Nordic Lead for Monitor Deloitte and Managing Director of Accenture Denmark.
Nicolai Hesdorf Chair of the Board of Directors
Camilla Harder Hartvig
TOUCH
Camilla Harder Hartvig Board MemberCamilla brings nearly 30 years of global pharmaceutical leadership, holding senior roles at AstraZeneca, Novartis, Allergan, Alexion, Theramex, and most recently EVP, President, International at Ascendis. Her career spans global commercial and executive leadership roles.
Camilla Harder Hartvig Board Member
Alexander Peitersen
TOUCH
Alexander Peitersen Board MemberAlexander has 25 years of experience as an international strategy and communications advisor, supporting C-suite leaders at global biopharmaceutical companies on life science branding, digital strategy, and commercialisation. He is founder of the strategic advisory firm &Now, and co-founder of the communications firm REPUTATION.
Alexander Peitersen Board Member
Show more